The FDA has delayed granting full approval of Novavax's COVID-19 vaccine despite it being on track to be cleared until ...
Immunology is pivotal in addressing significant health challenges, from enhancing vaccine efficacy to identifying therapeutic targets for complex diseases.
Formation Bio, an AI-driven pharmaceutical company revolutionizing drug development, today announced that Mikael Dolsten, MD, PhD, former Chief Scientific Officer and President, Pfizer Research & ...
Vaccines are a powerful tool of modern medicine, protecting you from diseases that once caused widespread suffering and death ...
In this first part of our interview with Ezgi Gürler of Females in Mass Spectrometry, we ask about her contributions to developing the glycoconjugate vaccine candidates (ExPEC Next Generation) at ...
Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...
Pfizer and Flagship Pioneering are turning to autoimmune disease as the sixth plank of their multibillion-dollar, 10-program ...
Pharmaceutical Technology on MSN2d
Pfizer’s RSV vaccine wins expanded approval in EU, gaining edge over GSKAbrysvo is now approved in the EU for adults aged 18 to 59 who are at increased risk of lower respiratory tract disease ...
Vaxcyte’s stock has dropped around 45% despite a Phase II trial of its invasive pneumococcal disease (IPD) vaccine meeting ...
2dOpinion
The claim of a link between vaccines and autism has been decisively debunked. Why has RFK Jr. put one of its promoters in ...
The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...
Shares in Moderna, Vaxcyte, Novavax and BioNTech all fell Monday after Peter Marks, head of the FDA office that reviews ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback